Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolar proton pump.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI116194PMID 7678608PMCID PMC330035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vertebral bone resorptionin vitro: Effects of parathyroid hormone, calcitonin, 1,25 dihydroxyvitamin D3, epidermal growth factor, prostaglandin E2, and estrogen

  2007cited by this paper
• Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src

  1991cited by this paper
• Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

  1991cited by this paper
• Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay.

  1991cited by this paper
• Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype

  1991cited by this paper
• The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

  1990cited by this paper
• Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long-term human marrow cultures.

  1990cited by this paper
• Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

  1990cited by this paper
• Rapid publication: Impairment of macrophage colony‐stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op Mouse

  1990cited by this paper
• The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

  1989cited by this paper
• The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor

  1989cited by this paper
• Osteoclastic bone resorption by a polarized vacuolar proton pump.

  1989cited by this paper
• Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.

  1989cited by this paper
• Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.

  1989cited by this paper
• Osteoblastic cells are involved in osteoclast formation.

  1988cited by this paper
• Craniometaphyseal dysplasia with increased bone turnover and secondary hyperparathyroidism: therapeutic effect of calcitonin.

  1988cited by this paper
• Treatment of craniometaphyseal dysplasia with calcitriol.

  1988cited by this paper
• Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

  1988cited by this paper
• Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.

  1987cited by this paper
• Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures.

  1987cited by this paper
• In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population

  1986cited by this paper
• Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.

  1985cited by this paper
• Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.

  1984cited by this paper
• Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses

  1983cited by this paper
• Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation

  1982cited by this paper
• Transformations of osteoclast phenotype in ia rats cured of congenital osteopetrosis

  1982cited by this paper
• The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors.

  1981cited by this paper
• Autosomal recessive craniometaphyseal dysplasia.

  1980cited by this paper
• Radiology of the autosomal dominant form of craniometaphyseal dysplasia.

  1975cited by this paper
• Craniofacial surgery in craniometaphyseal dysplasia.

  1968cited by this paper
• OSTEOPETROSIS: A Clinical, Genetic, Metabolic, and Morphologic Study of the Dominantly Inherited, Benign Form

  1968cited by this paper
• Craniofacial surgery in craniometaphyseal dysplasia

  1967cited by this paper
• Familial Metaphyseal Dysplasia

  1967cited by this paper
• [CRANIOMETAPHYSIAL DYSPLASIA (PYLE)].

  1965cited by this paper

• Skeletal abnormalities caused by a Connexin43R239Q mutation in a mouse model for autosomal recessive craniometaphyseal dysplasia

  2025cites this paper
• Skeletal abnormalities caused by a Connexin43R239Q mutation in a mouse model for autosomal recessive craniometaphyseal dysplasia

  2024cites this paper
• Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia

  2023cites this paper
• WITHDRAWN: Inorganic Pyrophosphate Promotes Osteoclastogenic Commitment and Survival of Bone Marrow Derived Monocytes mediated by Egr-1 up-regulation and MITF phosphorylation

  2020cites this paper
• Craniometaphyseal Dysplasia Mutations in ANKH Negatively Affect Human Induced Pluripotent Stem Cell Differentiation into Osteoclasts

  2017influential citation
• Craniometaphyseal dysplasia: the need for a natural history of disease study

  2016influential citation
• Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia

  2016cites this paper
• Molecular, Phenotypic Aspects and Therapeutic Horizons of Rare Genetic Bone Disorders

  2014cites this paper
• Sclerosing bone dysplasias with involvement of the craniofacial skeleton.

  2014cites this paper
• Chiari type I malformation caused by craniometaphyseal dysplasia.

  2013cites this paper
• Genetics and Mechanisms of Crystal Deposition in Calcium Pyrophosphate Deposition Disease

  2012cites this paper
• Cell-based resorption assays for bone graft substitutes.

  2012cites this paper
• Craniometaphyseal dysplasia unnoticed until 19 years of age: First diagnosed from facial nerve paralysis.

  2011cites this paper
• A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).

  2011cites this paper
• Novel ANKH mutation in a patient with sporadic craniometaphyseal dysplasia

  2010cites this paper
• Introduction of a Phe377del Mutation in ANK Creates a Mouse Model for Craniometaphyseal Dysplasia

  2009influential citation
• Development and Differentiation of Macrophages and Related Cells: Historical Review and Current Concepts

  2009cites this paper
• Osteoclast Function: Biology and Mechanisms

  2008cites this paper
• Clinical approach to clarifying the mechanism of abnormal bone metabolism in McCune–Albright syndrome

  2005cites this paper
• Mechanism of osteoclast-mediated bone resorption

  2005cites this paper
• Craniometaphyseal dysplasia

  2005cites this paper
• Craniometaphyseal dysplasia: a case report and review of medical and surgical management.

  2003cites this paper
• Craniometaphyseal dysplasia: a case report and review of medical and surgical management.

  2003cites this paper
• Craniometaphyseal dysplasia: ophthalmic features and management.

  2003cites this paper
• Chapter 3 – Osteoclast Biology

  2001cites this paper
• Development and Differentiation of Macrophages and Related Cells

  2001cites this paper
• Pyrophosphate, an old actor in two new roles

  2001cites this paper
• Tooth eruption in a patient with craniometaphyseal dysplasia: case report.

  2000cites this paper
• Mapping of the autosomal recessive (AR) craniometaphyseal dysplasia locus to chromosome region 6q21-22 and confirmation of genetic heterogeneity for mild AR spondylocostal dysplasia.

  2000cites this paper
• Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.

  1999cites this paper
• Decreased Bone Resorption, Osteoclast Differentiation, and Expression of Vacuolar H+-ATPase in Antisense DNA-Treated Mouse Metacarpal and Calvaria Cultures Ex Vivo

  1999cites this paper
• Tyro 3 Receptor Tyrosine Kinase and its Ligand, Gas6, Stimulate the Function of Osteoclasts

  1998cites this paper
• Craniometaphyseal dysplasia in six generations of a German kindred.

  1998cites this paper
• Chapter 1 – Embryology and Cellular Biology of Bone

  1998cites this paper
• Osteopetrosis in mice lacking haematopoietic transcription factor PU.1

  1997cites this paper
• The gene for autosomal dominant craniometaphyseal dysplasia maps to chromosome 5p and is distinct from the growth hormone-receptor gene.

  1997cites this paper
• Craniotubular dysplasia with severe postnatal growth retardation, mental retardation, ectodermal dysplasia, and loose skin: Lenz-Majewski-like syndrome.

  1997cites this paper
• Osteoclastic Bone Resorption: Normal and Pathological

  1997cites this paper
• Intracranial calcifications, epilepsy, and optic atrophy associated with metaphyseal dysplasia: a case report.

  1997cites this paper
• Osteoclasts, macrophages, and the molecular mechanisms of bone resorption

  1997cites this paper
• Foramen magnum decompression for cervicomedullary encroachment in craniometaphyseal dysplasia: case report.

  1997cites this paper
• Searching for gene defects that cause high bone mass.

  1997cites this paper
• Craniometaphyseal and craniodiaphyseal dysplasia, head and neck manifestations and management

  1996cites this paper
• Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.

  1996cites this paper
• The osteoclast and osteoporosis.

  1996cites this paper
• Recent developments in the understanding of the pathophysiology of osteopetrosis.

  1996cites this paper
• Autosomal-dominante kraniometaphysäre Dysplasie

  1996cites this paper
• Lexikon der Syndrome und Fehlbildungen

  1995cites this paper
• Craniometaphyseal dysplasia (CMD), autosomal dominant form.

  1995cites this paper
• Molecular mechanisms of bone resorption

  1995cites this paper
• Syndrome of the month Craniometaphyseal dysplasia (CMD), autosomal dominant form

  year unknowncites this paper